E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 333.45 INR -5.15% Market Closed
Market Cap: 252.2B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Income Statement

Earnings Waterfall
Emcure Pharmaceuticals Ltd

Revenue
66.6B INR
Cost of Revenue
-26B INR
Gross Profit
40.6B INR
Operating Expenses
-31.5B INR
Operating Income
9.2B INR
Other Expenses
-4.2B INR
Net Income
5B INR

Income Statement
Emcure Pharmaceuticals Ltd

Rotate your device to view
Income Statement
Currency: INR
Mar-2022 Mar-2023 Mar-2024
Revenue
Revenue
58 554
N/A
59 858
+2%
66 583
+11%
Gross Profit
Cost of Revenue
(23 304)
(23 691)
(25 955)
Gross Profit
35 250
N/A
36 167
+3%
40 628
+12%
Operating Income
Operating Expenses
(24 395)
(26 953)
(31 455)
Selling, General & Administrative
(14 088)
(16 054)
(19 133)
Depreciation & Amortization
(2 449)
(2 601)
(3 124)
Other Operating Expenses
(7 858)
(8 298)
(9 198)
Operating Income
10 855
N/A
9 214
-15%
9 173
0%
Pre-Tax Income
Interest Income Expense
(966)
(1 530)
(1 661)
Non-Reccuring Items
0
(61)
(99)
Gain/Loss on Disposition of Assets
(4)
(3)
72
Total Other Income
(159)
(147)
(213)
Pre-Tax Income
9 725
N/A
7 472
-23%
7 272
-3%
Net Income
Tax Provision
(2 700)
(1 854)
(1 997)
Income from Continuing Operations
7 026
5 618
5 276
Income to Minority Interest
(404)
(298)
(294)
Net Income (Common)
6 622
N/A
5 320
-20%
4 982
-6%
EPS (Diluted)
35.02
N/A
28.13
-20%
26.35
-6%

See Also

Discover More